Don Beeman has nearly 30 years experience in a variety of commercial roles with Merck & Co., Inc. and with start up experience at Topaz Pharmaceuticals, LLC. At Merck Mr. Beeman led the commercial operations of the billion dollar vaccine division. As a senior executive in the division, he was involved with research and manufacturing planning in addition to his line management responsibilities. Don’s experience covers numerous product launches including Pepcid®, Prilosec®, Singulair®, Fosamax®, and pre-launch planning for Gardisil®, Zostavax® and Rotateq® among others in both the U.S. and Australia. Don’s expertise and vision built Topaz, where he succeeded in raising start-up capital, outsourcing clinical development, building commercial plans and engaging potential partners.
